EET Biobank: A National Cancer Biorepository for Early-Phase Trials
Official title: EET Biobank Funding for 2026-2027
Funded at Research Inst Nationwide Children's Hosp · NIH-11512950 · Data updated 2026-11-12
A national biobank is expanding to collect and share high-quality cancer biospecimens and clinical data from patients in early-phase and experimental cancer trials to speed new treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst Nationwide Children's Hosp NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project start | September 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $2,110,316 |
| NIH project number | 3U24CA254445-06S1 |
| Project ID | NIH-11512950 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients enrolling in NCI-sponsored early-phase or experimental cancer trials, whose samples may be stored and used for research.
✕Less likely to help
Patients not participating in these trials or whose samples are not requested for banking would not directly benefit.
What this research studies
If you are part of an early-stage cancer trial, this project will collect and store tumor tissues, blood, and related clinical data to help researchers understand how therapies work. The Biobank links biospecimens with detailed treatment histories and outcomes to support future studies. It aims to standardize collection and sharing across multiple NCI-supported networks, improving access for scientists while protecting patient information. By enabling researchers to analyze samples from diverse cancers, it may accelerate the development of new, potentially effective therapies.
Why it matters
Potential benefit: If successful, patients could benefit from faster development of better cancer treatments and more precise medical insights from their own samples.
How similar studies have gone: Previous cancer biobanks have shown that standardized biospecimens linked with clinical data can accelerate translational research and drug development.
Where this research is happening
-
Research Inst Nationwide Children's Hosp
Columbus, United States Active
Researchers
- Principal investigator: Nicol, Kathleen — Research Inst Nationwide Children's Hosp
- Study coordinator: Nicol, Kathleen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.